Karolinska Development (STO:KDEV) has stopped investing in three of its portfolio biotechs and fully written off its outlay in the businesses to date. The decisions contributed to the valuation of the ...

Karolinska Development (STO:KDEV) has slashed the value of its portfolio after adopting a new way of tallying up what its early-stage biotech investments are worth. The new accounting model and the ...

This article is intended for those of you who are at the beginning of your investing journey and want to better understand how you can grow your money by investing in Karolinska Development AB (publ) ...

Karolinska Development AB ( (SE:KDEV)) has issued an announcement. Karolinska Development’s portfolio company, SVF Vaccines, has presented promising preclinical data on its immunotherapy, SVF-001, ...

Karolinska Development [KDEV], developer of life science innovations that meet tomorrow's medical need, will visit the NASDAQ MarketSite in Times Square. In honor of the occasion, Torbjörn Bjerke, CEO ...

Karolinska Development AB ( (SE:KDEV)) has issued an update. Karolinska Development’s portfolio company, Modus Therapeutics, has initiated dosing in the second part of a phase 2a clinical study for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

New firm will include existing portfolio company Akinion and four to five new project businesses. Swedish life science investor and incubator organization Karolinska Development has established a new ...